Xeris Biopharma Holdings, Inc. XERS Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $12.01M+2,068% | $554K+104% | -$15.64M+51.1% | -$32M+29.0% | -$45.08M+17.8% | ||
| $1.34M+1.7% | $1.31M+1.7% | $1.29M+2.5% | $1.26M+3.6% | $1.22M-0.9% | ||
| $22.06M-1.4% | $22.37M+8.1% | $20.69M+4.4% | $19.81M+4.1% | $19.04M+3.7% | ||
| $48.53M+69.5% | $28.63M+234% | $8.58M+147% | -$18.15M+36.7% | -$28.68M+26.4% | ||
| -$1.01M-44.8% | -$696K-107% | $9.65M— | —— | —— | ||
| —— | —— | —— | —— | -$2.08M-106% | ||
| $53.21M+35.3% | $39.32M+21.9% | $32.26M+1,943% | $1.58M+136% | -$4.35M-207% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Xeris Biopharma Holdings, Inc. generate?
- Xeris Biopharma Holdings, Inc. (XERS) generated $48.5M in operating cash flow over the trailing twelve months.
- Where does Xeris Biopharma Holdings, Inc.'s cash flow data come from?
- Every line is extracted from Xeris Biopharma Holdings, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
